Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company Vertex Pharmaceuticals on Thursday. The drug, which is called suzetrigine ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
Robert F. Kennedy Jr. has big plans for the FDA if he's confirmed as Secretary of Health and Human Services. FDA Commissioner Robert Califf explains why certain changes may not be that easy — or ...